Skip to main content
. 2021 Sep 3;16:6141–6156. doi: 10.2147/IJN.S311248

Figure 3.

Figure 3

Schematic illustration of the fabrication of Ag@MSNs@LEVO nanoplatform and its application for a synergistic therapy of drug-resistant infections in vitro and in vivo. The silver core is the supplier of silver source, and the shell of mesoporous silica acts as the drug storage and release channel, which endows the single particle nano-platform with the ability to release antibiotics and silver tower simultaneously.